24 results
424B5
GLUE
Monte Rosa Therapeutics Inc
26 Oct 23
Prospectus supplement for primary offering
4:55pm
and Results of Operations” disclosure;
reduced disclosure about our executive compensation arrangements;
not being required to hold advisory votes … on executive compensation or to obtain stockholder approval of any golden parachute arrangements not previously approved; and
an exemption from the auditor
PRE 14A
69m99znszuleon
12 Apr 23
Preliminary proxy
4:07pm
S-3
bo3dgz 7rq7eksbaaaq
1 Jul 22
Shelf registration
5:01pm
DEFA14A
yewsemf 6bu
8 Jun 22
Additional proxy soliciting materials
4:11pm
DEF 14A
u2shd7qg98h
27 Apr 22
Definitive proxy
4:10pm
10-K
0ok5b8enqhy2hjb
29 Mar 22
Annual report
4:15pm
10-Q
75ekh3pzhka2ckpzgo8
12 Aug 21
Quarterly report
4:22pm
424B4
fk1x55m9c5pwz8rcr767
25 Jun 21
Prospectus supplement with pricing info
6:08am